Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
September 6, 2022
Patent Application Number
16417859
Date Filed
May 21, 2019
Patent Citations Received
Patent Primary Examiner
The present invention provides novel antibodies that specifically bind to CD3 and uses thereof. The invention also provides therapeutic and diagnostic methods utilizing the antibodies and antigen-binding fragments provided herein.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
